Resources Contact Us Home
Humanized anti-CD70 binding agents and uses thereof

Image Number 17 for United States Patent #8067546.

Disclosed are CD70 binding agents, such as humanized anti-CD70 antibodies and fragments and derivatives, that exert a cytotoxic, cytostatic or immunomodulatory on CD70 expressing cells, as well as pharmaceutical compositions and kits comprising the antibody, fragment or derivative. Also disclosed are methods for the treatment of CD70-expressing cancers and immunological disorders, comprising administering to a subject the CD70 binding agents or pharmaceutical compositions.

  Recently Added Patents
(-)-epigallocatechin gallate derivatives for inhibiting proteasome
Avirulent oncolytic herpes simplex virus strains engineered to counter the innate host response
Buckle (tube)
Endotracheal tube
Method, apparatus or computer program for changing from scheduled to unscheduled communication modes
System and method for redirected firewall discovery in a network environment
Method of processing data and display apparatus for performing the method
  Randomly Featured Patents
Interleukin-10 antibodies
Vehicle body construction
Non-lethal projectiles for delivering an inhibiting substance to a living target
Spiral lead platen robotic end effector
Methods involving maps, imagery, video and steganography
Screw propellor protection device for boats
Synchronized spindle control in disk drives with at least two data per rotation of disk
Formation of thin channels for TFT devices to ensure low variability of threshold voltages
Amplifier provided at output stage of intermediate frequency amplifying circuit of mobile communication system
Variable blazed grating